Skandinaviska Enskilda Banken AB publ increased its holdings in The Clorox Company (NYSE:CLX – Free Report) by 29.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,107 shares of the company’s stock after purchasing an additional 9,800 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in Clorox were worth $6,958,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the business. Brooklyn Investment Group increased its holdings in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares in the last quarter. Prospera Private Wealth LLC acquired a new position in shares of Clorox in the 3rd quarter worth $27,000. Continuum Advisory LLC raised its position in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the period. Asset Planning Inc purchased a new stake in shares of Clorox during the fourth quarter valued at $32,000. Finally, Halbert Hargrove Global Advisors LLC purchased a new position in Clorox in the 4th quarter worth about $36,000. 78.53% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research analysts have commented on the stock. Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. DA Davidson dropped their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. JPMorgan Chase & Co. raised their price objective on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Finally, Barclays increased their price target on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 5th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $159.62.
Clorox Stock Up 0.3 %
CLX stock opened at $147.32 on Friday. The firm has a market cap of $18.15 billion, a PE ratio of 40.25, a PEG ratio of 2.62 and a beta of 0.45. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a fifty day simple moving average of $154.20 and a 200 day simple moving average of $160.20. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the company earned $2.16 earnings per share. Sell-side analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.
Clorox Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.31%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio is currently 133.33%.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- The 3 Best Fintech Stocks to Buy Now
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What Does a Stock Split Mean?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What Are Growth Stocks and Investing in Them
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.